411 related articles for article (PubMed ID: 17183367)
21. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
22. Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.
Nihira K; Ando Y; Yamaguchi T; Kagami Y; Miki Y; Yoshida K
Cell Death Differ; 2010 Apr; 17(4):689-98. PubMed ID: 19911008
[TBL] [Abstract][Full Text] [Related]
23. WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination.
Zhang J; Yu Y; Zou X; Du Y; Liang Q; Gong M; He Y; Luo J; Wu D; Jiang X; Sinclair M; Tajkhorshid E; Chen HZ; Hou Z; Zheng Y; Chen LF; Yang XD
Nucleic Acids Res; 2024 May; 52(9):4969-4984. PubMed ID: 38452206
[TBL] [Abstract][Full Text] [Related]
24. Regulatory effect of SOCS on NF-kappaB activity in murine monocytes/macrophages.
Park SH; Kim KE; Hwang HY; Kim TY
DNA Cell Biol; 2003 Feb; 22(2):131-9. PubMed ID: 12713738
[TBL] [Abstract][Full Text] [Related]
25. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
[TBL] [Abstract][Full Text] [Related]
26. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M
Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611
[TBL] [Abstract][Full Text] [Related]
27. MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses.
Shin C; Ito Y; Ichikawa S; Tokunaga M; Sakata-Sogawa K; Tanaka T
Sci Rep; 2017 Apr; 7():46097. PubMed ID: 28378844
[TBL] [Abstract][Full Text] [Related]
28. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
[TBL] [Abstract][Full Text] [Related]
29. IL-17 receptor signaling: ubiquitin gets in on the act.
Levin SD
Sci Signal; 2009 Oct; 2(92):pe64. PubMed ID: 19825826
[TBL] [Abstract][Full Text] [Related]
30. Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.
Zoubeidi A; Ettinger S; Beraldi E; Hadaschik B; Zardan A; Klomp LW; Nelson CC; Rennie PS; Gleave ME
Mol Cancer Res; 2010 Jan; 8(1):119-30. PubMed ID: 20068069
[TBL] [Abstract][Full Text] [Related]
31. Non-proteolytic ubiquitination of OTULIN regulates NF-κB signaling pathway.
Zhao M; Song K; Hao W; Wang L; Patil G; Li Q; Xu L; Hua F; Fu B; Schwamborn JC; Dorf ME; Li S
J Mol Cell Biol; 2020 Apr; 12(3):163-175. PubMed ID: 31504727
[TBL] [Abstract][Full Text] [Related]
32. Linear ubiquitination: a novel NF-κB regulatory mechanism for inflammatory and immune responses by the LUBAC ubiquitin ligase complex.
Tokunaga F; Iwai K
Endocr J; 2012; 59(8):641-52. PubMed ID: 22673407
[TBL] [Abstract][Full Text] [Related]
33. Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation.
Hou Y; Zhang Z; Xu Q; Wang H; Xu Y; Chen K
Oncogene; 2014 Apr; 33(15):1997-2003. PubMed ID: 23624912
[TBL] [Abstract][Full Text] [Related]
34. CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1.
Lo SC; Hannink M
Mol Cell Biol; 2006 Feb; 26(4):1235-44. PubMed ID: 16449638
[TBL] [Abstract][Full Text] [Related]
35. Brap2 regulates temporal control of NF-κB localization mediated by inflammatory response.
Takashima O; Tsuruta F; Kigoshi Y; Nakamura S; Kim J; Katoh MC; Fukuda T; Irie K; Chiba T
PLoS One; 2013; 8(3):e58911. PubMed ID: 23554956
[TBL] [Abstract][Full Text] [Related]
36. Linear ubiquitination-mediated NF-κB regulation and its related disorders.
Tokunaga F
J Biochem; 2013 Oct; 154(4):313-23. PubMed ID: 23969028
[TBL] [Abstract][Full Text] [Related]
37. Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus.
Strebovsky J; Walker P; Lang R; Dalpke AH
FASEB J; 2011 Mar; 25(3):863-74. PubMed ID: 21084693
[TBL] [Abstract][Full Text] [Related]
38. A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded Vpx.
Landsberg CD; Megger DA; Hotter D; Rückborn MU; Eilbrecht M; Rashidi-Alavijeh J; Howe S; Heinrichs S; Sauter D; Sitek B; Le-Trilling VTK; Trilling M
Front Immunol; 2018; 9():2978. PubMed ID: 30619335
[TBL] [Abstract][Full Text] [Related]
39. Control of NF-κB subunits by ubiquitination.
Collins PE; Colleran A; Carmody RJ
Methods Mol Biol; 2015; 1280():355-70. PubMed ID: 25736760
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
Karin M; Ben-Neriah Y
Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
